亨迪药业
(301211)
| 流通市值：42.59亿 | | | 总市值：42.60亿 |
| 流通股本：4.18亿 | | | 总股本：4.18亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 354,425,267.77 | 247,515,604.46 | 120,164,148.88 | 453,306,981.13 |
| 营业总成本 | 343,756,681.94 | 238,669,614.7 | 119,112,800.57 | 439,869,142.57 |
| 其他经营收益 | | | | |
| 营业利润 | 42,950,111.11 | 33,399,779.92 | 10,250,432.23 | 41,855,619.79 |
| 利润总额 | 42,825,055.73 | 33,392,929.21 | 10,250,012.6 | 41,260,938 |
| 净利润 | 39,657,775.3 | 30,136,061.88 | 9,218,063.65 | 34,910,598.79 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | 628,950.39 |
| 综合收益总额 | 39,657,775.3 | 30,136,061.88 | 9,218,063.65 | 35,539,549.18 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 1,777,198,147.1 | 1,785,061,880.06 | 1,792,208,176.15 | 1,791,603,630.53 |
| 非流动资产: | | | | |
| 非流动资产合计 | 614,346,878.96 | 607,244,561.36 | 607,911,133.39 | 610,273,637.81 |
| 资产总计 | 2,391,545,026.06 | 2,392,306,441.42 | 2,400,119,309.54 | 2,401,877,268.34 |
| 流动负债: | | | | |
| 流动负债合计 | 91,186,514.89 | 101,128,660.87 | 104,325,583.27 | 114,549,840.55 |
| 非流动负债: | | | | |
| 非流动负债合计 | 12,474,920.37 | 12,869,636.33 | 13,304,797.27 | 14,099,345.45 |
| 负债合计 | 103,661,435.26 | 113,998,297.2 | 117,630,380.54 | 128,649,186 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 2,287,883,590.8 | 2,278,308,144.22 | 2,282,488,929 | 2,273,228,082.34 |
| 股东权益合计 | 2,287,883,590.8 | 2,278,308,144.22 | 2,282,488,929 | 2,273,228,082.34 |
| 负债和股东权益合计 | 2,391,545,026.06 | 2,392,306,441.42 | 2,400,119,309.54 | 2,401,877,268.34 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 299,789,274.17 | 211,580,984.15 | 111,600,280.46 | 406,788,250.41 |
| 经营活动现金流出小计 | 279,618,512.94 | 178,892,946.94 | 114,063,094.46 | 399,237,430.95 |
| 经营活动产生的现金流量净额 | 20,170,761.23 | 32,688,037.21 | -2,462,814 | 7,550,819.46 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 135,649 | 69,000 | - | 490,749,331.64 |
| 投资活动现金流出小计 | 54,329,523.57 | 34,526,651.43 | 19,186,893.06 | 528,037,293.92 |
| 投资活动产生的现金流量净额 | -54,193,874.57 | -34,457,651.43 | -19,186,893.06 | -37,287,962.28 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | - | - | - | - |
| 筹资活动现金流出小计 | 25,056,000 | 26,324,079.16 | - | 73,402,643.11 |
| 筹资活动产生的现金流量净额 | -25,056,000 | -26,324,079.16 | - | -73,402,643.11 |
| 汇率变动对现金及现金等价物的影响 | -3,071,283.97 | -1,987,849.21 | -725,827.95 | -1,141,506.19 |
| 现金及现金等价物净增加额 | -62,150,397.31 | -30,081,542.59 | -22,375,535.01 | -104,281,292.12 |
| 期末现金及现金等价物余额 | 376,608,102.2 | 408,676,956.92 | 425,282,964.5 | 438,758,499.51 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | -30,081,542.59 | - | -104,281,292.12 |